TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ProPharma Group Sweden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
7,460
|
8,634
|
8,756 |
| Financial expenses |
128
|
130
|
1 |
| Earnings before taxes |
-1,790
|
-330
|
-448 |
| EBITDA |
-1,656
|
-383
|
-431 |
| Total assets |
4,353
|
5,999
|
4,727 |
| Current assets |
4,317
|
5,951
|
4,667 |
| Current liabilities |
2,823
|
4,003
|
2,408 |
| Equity capital |
1,530
|
1,758
|
2,022 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
55
|
57
|
65 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.1%
|
29.3%
|
42.8% |
| Turnover per employee |
136
|
151
|
135 |
| Profit as a percentage of turnover |
-24.0%
|
-3.8%
|
-5.1% |
| Return on assets (ROA) |
-38.2%
|
-3.3%
|
-9.5% |
| Current ratio |
152.9%
|
148.7%
|
193.8% |
| Return on equity (ROE) |
-117.0%
|
-18.8%
|
-22.2% |
| Change turnover |
-881
|
-148
|
57 |
| Change turnover % |
-11%
|
-2%
|
1% |
| Chg. No. of employees |
-2
|
-8
|
8 |
| Chg. No. of employees % |
-4%
|
-12%
|
14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.